Unum Therapeutics Inc. | 200 Cambridge Park Drive Suite 3100 | Cambridge, MA 02140  USA

Tel. +1.617.945.5576 | Email: info@unumrx.com

  • LinkedIn - White Circle
  • Twitter - White Circle

© Copyright 2014-2019 Unum Therapeutics


Bruce Booth, DPhil

Board Chair; Partner, Atlas Ventures


Joern Aldag

 CEO, Hookipa Biotech AG


Karen Ferrante

 Medical Oncologist and former Pharma-Biotech Executive



Rob Perez

Managing Director, Vineyard Sound Advisors



Liam Ratcliffe, MD, PhD

Managing Director, New Leaf Venture Partners



Charles "Chuck" Wilson, PhD

CEO, Unum Therapeutics


Ben Auspitz

Partner, F-Prime Capital

Ben is a Partner at F-Prime Capital, and has worked in pharmaceuticals and life-sciences for over fifteen years, both in industry, as a consultant, and as an investor. Ben focuses on therapeutics, with a particular interest in Series A and company formation. He currently serves on the Board of Directors of Unum Therapeutics, Precision Biosciences, and Symbiomix Pharmaceuticals, and is Chairman of the Board of Dimension Therapeutics. Most recently before joining F-Prime Capital, he served as Therapeutic Area Head for Immuno-Inflammatory products at CombinatoRx Inc. during its growth from an angel-backed start-up to a publicly-listed company. He holds a Bachelors of Arts from Harvard University.